Applied Genetic Technology Tumbles 32% On Eye Study Problems
September 13, 2016 at 15:49 PM EDT
Applied Genetic Technology tumbled 32% after reporting problems with its gene trial in treating patients with a rare eye disorder.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|